首页 | 本学科首页   官方微博 | 高级检索  
检索        

p-mTOR、P-p70S6K蛋白在膀胱尿路上皮癌中的表达
引用本文:陈业刚,杨拓,刘鹏,王建民,孙光.p-mTOR、P-p70S6K蛋白在膀胱尿路上皮癌中的表达[J].中国中西医结合外科杂志,2013(6):639-642.
作者姓名:陈业刚  杨拓  刘鹏  王建民  孙光
作者单位:[1]天津市南开医院泌尿外科,天津300100 [2]天津医科大学第二医院泌尿外科,天津300211
摘    要:目的:探讨哺乳动物雷帕霉素靶蛋白(mTOR)通路蛋白(p-mTOR)、核糖体蛋白s6激酶(p-p70S6K)在膀胱尿路上皮癌中的表达情况及与预后的关系。方法:利用免疫组化染色检测mTOR通路蛋白p-mTOR、P-p70S6K在膀胱尿路上皮癌中的表达情况,分析p-mTOR、P-p70S6K在不同膀胱组织中的表达差异,与膀胱癌临床病理参数的关系及与膀胱尿路上皮癌预后的关系。结果:p-mTOR在膀胱尿路上皮癌中的阳性表达率(43.3%)高于正常黏膜(17.5%),p-mTOR表达阳性率随着肿瘤分级分期的增加相应增加,多发性膀胱尿路上皮癌p-mTOR表达阳性率(70.5%)高于单发组(31.4%),复发组(70.5%)高于未复发组(31.4%,P〈0.01);P-p70S6K在膀胱尿路上皮癌阳性率(25.9%)高于正常膀胱黏膜(7.5%,P〈0.05),p-p70S6K表达阳性率随着肿瘤分级分期的增加相应增加,多发性膀胱尿路上皮癌p-p70S6K表达阳性率(45.9%)高于单发组(17.1%),复发组(30.3%)高于未复发组(17.4%,P〈0.01);肿瘤分级、分期、数目及p-mTOR表达分别是膀胱肿瘤无瘤生存的独立预后因子。结论:mTOR/p-mTOR/p-p70S6K通路的激活与膀胱尿路上皮癌的发生发展有关,p-mTOR可以作为预测膀胱尿路上皮癌复发的预后因子。

关 键 词:哺乳动物雷帕霉素靶蛋白  核糖体蛋白s6激酶  膀胱尿路上皮癌  蛋白表达

Expression of p-mTOR and p-p70S6K in Urothelial Bladder Cancer
Institution:CHEN Ye-gang, YANG Tuo, LIU Peng, et al( Department of Urology, Tianjin Nankai Hospital, Tianjin (300100), China)
Abstract:Objective To investigate the expression of p-mTOR and p-p70S6K in human bladder cancer tissues and the correlation with the prognosis. Methods The expression of p-mTOR and p-p70S6K was de- tected in normal bladder tissues and bladder cancer tissues by immunohistochemistry. Their relationship with clinicopathological characteristics and prognosis was analysed by Kaplan-Meier method and Log rank test. Results The expression of p-roTOR in bladder cancer tissues was 43.3%, higher than 17.5% in normal blad- der tussues. The positive rate of p-mTOR expression increased with the progress of pathological stage and tumor grade. The expression of p-roTOR was 70.5% in multiple bladder tumors, higher than 31.4% in single bladder tumor; 70.5% with positive expression of p-mTOR relapsed, higher than 31.4% without recurrence. The expres- sion of p-p70S6K in bladder cancer tissues was 25.9%, higher than 7.5% in normal bladder tussues. The posi- tive rate of p-pTOS6K expression increased with the progress of pathological staging and tumor grade. The ex- pression of p-p70S6K was 45.9% in multiple bladder tumors than 17.1% in single bladder tumor; 30.3% with positive expression of p-p70S6K relapsed, higher than 17.4% without recurrence. The difference was statistical significant. The pathological staging, tissue grade, number of tumors and expression of p-roTOR were identified as independent prognostic factors for bladder cancer by univariate and multivariate Cox regression analysis. Conclusion The mTOR/p-mTOR/p-p70S6K pathway was correlated with tumor oncology and tumor progress, p-mTOR protein was an independent prognostic factor for bladder cancer.
Keywords:Mammalian target of rapamycin  ribosomal protein S6 kinase  urothelial bladder cancer
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号